(Reuters) – Gilead Sciences Inc <GILD.O> will acquire biopharmaceutical company Immunomedics Inc <IMMU.O> for $21 billion, a move that will strengthen its cancer portfolio by gaining acce… [+1615 chars]
Gilead to buy cancer drugmaker Immunomedics for $21 billion – Yahoo Finance
